BioAtla, Inc.
BCAB
$0.356
-$0.0002-0.06%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 43.08% | 48.11% | 43.48% | 34.06% | 10.28% |
| Total Depreciation and Amortization | -31.89% | -25.68% | -24.24% | -7.47% | -6.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -56.96% | -54.39% | -40.10% | -32.02% | -23.16% |
| Change in Net Operating Assets | 111.29% | 69.04% | -339.29% | -238.11% | -354.26% |
| Cash from Operations | 51.23% | 48.84% | 30.84% | 13.58% | -12.80% |
| Capital Expenditure | -- | -- | -- | 93.39% | 78.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 93.39% | 78.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,199.75% | 2,744.35% | 2,744.35% | -99.37% | -99.34% |
| Repurchase of Common Stock | 58.97% | 60.26% | 82.24% | 81.73% | 74.40% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,957.93% | 4,971.67% | 12,251.95% | -99.49% | -99.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 59.40% | 56.93% | 40.00% | -130.10% | -218.57% |